论文部分内容阅读
作者比较了单纯应用强的松(对照组)和强的松加中药扶正强筋片(实验组)对重症肌无力(MG)的治疗效果。结果表明:症状完全缓解者对照组为 28.89％,实验组为 53.33％。复发率对照组为37.78％,实验组为 4.44％。两组症状完全缓解率和复发率比较差异均有显著性意义(P<0.05和 P<0.01)。两组治疗前后乙酰胆碱受体抗体(AChRab)均值比较和治疗前后差值平均数的比较,差异均有极显著性意义(P<0.01)。表明中药扶正强筋片是治疗MG的一种安全、有效的辅助药物。
The authors compared the therapeutic effects of prednisone (control) and prednisone plus Chinese medicine Fuzhengqiangjin tablets (experimental group) on myasthenia gravis (MG). The results showed that the complete remission of symptoms was 28.89% in the control group and 53.33% in the experimental group. The recurrence rate was 37.78% in the control group and 4.44% in the experimental group. There were significant differences in the complete remission rate and relapse rate between the two groups (P<0.05 and P<0.01). Before and after treatment, the mean value of acetylcholine receptor antibody (AChRab) was compared with the mean difference before and after treatment, and there was a significant difference (P<0.01). It shows that Fuzhengqiangjin Tablets is a safe and effective auxiliary drug for the treatment of MG.